Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 41

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 41
---
2025. For more
information, see “The Merger Agreement—Non Solicitation; Window Shop Period” and “—Termination Fees.”

These provisions could discourage a potential third-party acquiror that might have an interest in acquiring all or a significant portion of
STAAR from considering or proposing an acquisition, even if the acquiror was prepared to pay a greater amount of value than the Merger Consideration that STAAR stockholders would be afforded by the Merger, or could result in a potential third-party
acquiror proposing to pay a lower amount of value to STAAR’s stockholders than they might otherwise have proposed due to the added expense of the termination fee that may become payable to Alcon in certain circumstances.

Lawsuits may be filed against STAAR or its directors or officers challenging the transactions contemplated by the Merger Agreement or the Merger, which could prevent or delay the completion of the Merger or result in the payment of damages.

Litigation relating to the Merger may be
filed against STAAR or its directors or officers. Among other remedies, claimants could seek damages and/or to enjoin the Merger and the other transactions contemplated by the Merger Agreement. An adverse ruling in any such lawsuit may delay or
prevent the proposed Merger from being completed. Any such actions may create uncertainty relating to the Merger and may be costly and distracting to STAAR’s management.

Additionally, if the Merger is not consummated for any reason, litigation could be filed in connection with the failure to consummate the
Merger.

-25-

If the Merger is consummated, STAAR stockholders will not be able to participate in any further upside to STAAR’s business.

If the Merger is consummated, STAAR stockholders will receive the right to receive $28.00 per share in
cash, without interest, subject to any required tax withholding, and will not receive any equity interests of Alcon. As a result, if STAAR’s business following the Merger performs well, STAAR’s current stockholders will not receive any
additional consideration and will therefore not receive any benefit from any such future performance of STAAR’s business.

-26-

THE SPECIAL MEETING

The enclosed proxy is solicited on behalf of the Board for use at the Special Meeting.

Date, Time and Place

The Special Meeting will be held virtually via live webcast on [ ], 2025, beginning at
[ ], Pacific Time (unless the Special Meeting